VEGFA and neoplasm: HPSE disrupts growth factor homeostasis by increasing bioavailability, as enzymatic cleavage of HS chains liberates HS-bound molecules such as FGF, HGF, and VEGF from the ECM, thereby activating signaling pathways in both tumor and stromal cells of the TME [95,96] (Figure 4).